About the journal

Having served as the founding editor of Oncogene from 1987 to 2008 and establishing Oncogene as one of the leading cancer journals, Dr. E. Premkumar Reddy launched the journal entitled Genes & Cancer in 2010 which publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Its Editorial Board consists of outstanding scientists who are well known for their contributions in the fields of oncogenes/oncoproteins, signal transduction, cancer therapy and other fields of biology and medicine.

One of the important goals of the Editorial Office is to shape this journal into a high impact journal. All papers appear in PMC and PubMed. Based on our calculation, Genes & Cancer will soon become a very high impact journal. Genes & Cancer is a member of the Committee on Publication Ethics (COPE) and other international committees.

Impact Journals, LLC meets the Wellcome Trust Publisher Requirements, and is now a member of the Wellcome Trust List of Compliant Publishers

Aims & Scope

Cancer research has entered a new and exciting phase where the convergence of information from genomics, bioinformatics and modern genetics are beginning to provide new clues into how cancer cells overcome growth regulatory pathways. To capture this excitement, Genes & Cancer covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. In addition to publishing manuscripts that directly relate to these areas of research, we hope to attract papers in the areas of genomics, drug development and systems biology.

News

According to Scopus/SJR/Journal rank, Genes & Cancer ranks Q1 (highest group), thus becoming a leading journal in the field of cancer and genetics.

Genes & Cancer is now offering Free Altmetric Article Reports as a new part of our Journal platform to provide real-time tracking of article coverage in digtial and traditional media channels, often long before traditional citations begin to accrue. Here are some resources where you can learn more about: Altmetric Analytic Software , Adding Altmetric data to your NIH Biosketch, What is the Altmetric donut , and How is your Altmetric score calculated

LATEST VOLUME

Editor-in-Chief

E. Premkumar Reddy, PhD Mount Sinai School of Medicine, New York, USA

Assistant Editor

Stacey J. Baker, PhD Mount Sinai School of Medicine, New York, USA

Editorial Board

Stuart Aaronson Mount Sinai School of Medicine, USA
Dario Altieri The Wistar Institute, USA
Bruno Amati European Institute of Oncology (IEO), Italy
Ralph Arlinghaus The University of Texas M. D. Anderson Cancer Center, USA
Mikhail Blagosklonny Roswell Park Cancer Center, USA
Benjamin Bonavida University of California, Los Angeles, USA
Eli Canaani The Ohio State University, USA
Michele Carbone University of Hawaii Cancer Research Center of Hawaii, USA
Lan Bo Chen Harvard Medical School, Dana-Farber Cancer Institute, USA
Colin Cooper Institute of Cancer Research, UK
Carlo Croce The Ohio State University Comprehensive Cancer Center, USA
Wei Dai New York University School of Medicine, USA
Chi Dang Abramson Cancer Center, University of Pennsylvania, USA
Peter Daniel University Medical Center Charité, Germany
Ronald Depinho University of Texas MD Anderson Cancer Center, USA
Channing Der University of North Carolina at Chapel Hill, USA
Danny Dhanasekaran University of Oklahoma Health Sciences Center, USA
Pier Paolo Di Fiore IFOM, Fondazione Istituto FIRC di Oncologia Molecolare at IFOMIEO, Italy
J. Alan Diehl University of Pennsylvania, USA
Vishva Dixit Genentech, Inc., USA
G. Paolo Dotto Massachusetts General Hospital, Harvard Cancer Center, USA
Manel Esteller Centro Nacional de Investigaciones Oncologicas (CNIO), Spain
Albert Fornace Jr. Georgetown University, The Lomabrdi Comprehensive Cancer Center, USA
Jon Frampton University of Birmingham, Institute of Biomedical Research, UK
Simone Fulda J.W. Goethe University Hospital Frankfurt, Germany
Donna George University of Pennsylvania, USA
Thomas Gilmore Boston University, USA
Doron Ginsberg Bar Ilan University, Israel
J. Silvio Gutkind National Institutes of Health, USA
Stephen Hann Vanderbilt University Medical Center, USA
Lothar Hennighausen National Institutes of Health, USA
Meenhard Herlyn The Wistar Institute, USA
Ciro Isidoro Università del Piemonte Orientale, Laboratory of Molecular Pathology and Nanobioimaging, Department of Health Sciences, Novara, Italy
Gary Johnson University of North Carolina School of Medicine, USA
Akira Kikuchi Hiroshima University, Japan
Erik Knudsen University of Texas Southwestern Medical Center, USA
H. Philip Koeffler National University of Singapore, USA
Guido Kroemer Institut Goustav Roussy, France
Donald Kufe Harvard Medical School, Dana-Farber Cancer Institute, USA
Rakesh Kumar George Washington University Medical Center, USA
Hsing Jien Kung University of California Davis Medical Center, USA
Arnold Levine The Institute for Advanced Study, USA
Edison Liu The Jackson Laboratory, USA
Yongzhang Luo Tsinghua University, National Engineering Laboratory for Anti-Tumor Protein Therapeutics, China
Marcos Malumbres Centro Nacional de Investigaciones Oncologicas (CNIO), Spain
Sridhar Mani Albert Einstein College of Medicine, USA
Lopa Mishra M.D. Anderson Cancer Center, USA
Kohei Miyazono University of Tokyo, Japan
Aristidis Moustakas Ludwig Institute for Cancer Research Ltd., Sweden
William Muller McGill University, Canada
Karl Munger Harvard University, Brigham and Women's Hospital, USA
Elizabeth Musgrove Cancer Research Program, Garvan Institute of Medical Research, Australia
Irene Oi-Lin Ng The University of Hong Kong, Hong Kong
Pier Paolo Pandolfi Harvard Medical School, Beth Israel Deaconess Medical Center, USA
Sarah Parsons University of Virginia, USA
Vivek Rangnekar University of Kentucky, USA
Roger Reddel University of Sydney, Australia
John C. Reed Roche Holding AG, Basel, Switzerland
Zea'ev Ronai Burnham Institute for Medical Research, USA
Martine Roussel St. Jude Children's Research Hospital, USA
Anil Rustgi University of Pennsylvania, USA
Eugenio Santos University of Salamanca, Centro de Investigacion del Cancer IBMCC (CSIC-USAL), Spain
Hideyuki Saya Keio University School of Medicine, Japan
Klaus Schulze-Osthoff University of Tübingen, Germany
Edward Seto Moffitt Cancer Center, USA
Yongfeng Shang Peking University Health Sciences Center, China
M. Saeed Sheikh SUNY Upstate Medical University, USA
Yigong Shi Tsinghua University School of Medicine, China
Tomasz Skorski Temple University School of Medicine, USA
Eric Solary Institut Gustave Roussy, France
Joseph Testa Fox Chase Cancer Center, USA
Yoshihide Tsujimoto Osaka University Graduate School of Medicine, Japan
Francois Valette Université de Nantes, INSERM UMR601, France
George Vande Woude Van Andel Research Center, USA
Peter Vogt The Scripps Research Institute, USA
Dennis Watson Hollings Cancer Center, Medical University of South Carolina, USA
Krister Wennerberg FIMM-EMBL Group Leader, Institute for Molecular Medicine, University of Helsinki, Finland
Xiang-Jiao Yang McGill University, Goodman Cancer Centre, Canada

Full Editorial Board

Interviews with outstanding authors

Interview with Dr. Magdalena Bieniasz from the Functional and Chemical Genomics Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA talking about their paper in Genes & Cancer Volume 7 Issue 5 - 6 "Short-form Ron is a novel determinant of ovarian cancer initiation and progression"

Request Conference Sponsorship